Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Index01:13

Therapeutic Index

6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Therapeutic Communication01:30

Therapeutic Communication

8.7K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.7K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.0K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Impact of short-term housing temperature alteration on metabolic parameters and adipose tissue in female mice.

Frontiers in endocrinology·2025
Same author

A new Col1a1 conditional knock-in mouse model to study osteogenesis imperfecta.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2024
Same author

A <i>Rab33b</i> missense mouse model for Smith-McCort dysplasia shows bone resorption defects and altered protein glycosylation.

Frontiers in genetics·2023
Same author

The NAD salvage pathway in mesenchymal cells is indispensable for skeletal development in mice.

Nature communications·2023
Same author

Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2.

Communications biology·2022

Related Experiment Video

Updated: Feb 13, 2026

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur
09:26

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur

Published on: October 23, 2017

7.9K

Osteogenesis imperfecta and therapeutics.

Roy Morello1

  • 1Department of Physiology & Biophysics, Orthopaedic Surgery, and Division of Genetics, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

Matrix Biology : Journal of the International Society for Matrix Biology
|March 16, 2018
PubMed
Summary
This summary is machine-generated.

Osteogenesis imperfecta (OI), or brittle bone disease, is a genetic disorder causing fragile bones. Research reveals its genetic basis and impact on extracellular matrix biology, offering insights into potential therapeutics.

Keywords:
BoneCollagenFragilityGeneticsMineralizationOsteogenesis imperfectaProteoglycans

More Related Videos

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
05:10

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

753
Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

18.8K

Related Experiment Videos

Last Updated: Feb 13, 2026

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur
09:26

An Efficient and Reproducible Protocol for Distraction Osteogenesis in a Rat Model Leading to a Functional Regenerated Femur

Published on: October 23, 2017

7.9K
Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
05:10

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

753
Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

18.8K

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Osteogenesis imperfecta (OI), or brittle bone disease, is a congenital disorder characterized by low bone mass and increased fracture risk.
  • While typically autosomal dominant, rarer recessive and X-linked forms exist, involving mutations beyond type I collagen.
  • OI affects multiple organs and provides insights into collagen synthesis and bone formation processes.

Purpose of the Study:

  • To review the clinical features and molecular genetics of Osteogenesis Imperfecta.
  • To elucidate how OI disrupts extracellular matrix biology.
  • To discuss current and potential therapeutics for OI.

Main Methods:

  • Literature review of clinical and genetic studies on Osteogenesis Imperfecta.
  • Analysis of molecular mechanisms underlying collagen synthesis and osteoblast function in OI.
  • Synthesis of information on the dysregulation of extracellular matrix biology in OI.

Main Results:

  • Identification of mutations in various genes, including type I collagen, impacting osteoblast differentiation and function.
  • Demonstration that OI significantly dysregulates multiple aspects of extracellular matrix biology.
  • Understanding of OI's genetic heterogeneity and its broad physiological consequences.

Conclusions:

  • Osteogenesis Imperfecta is a complex genetic disorder with far-reaching effects on bone and connective tissues.
  • Studying OI has significantly advanced our understanding of collagen synthesis, bone formation, and extracellular matrix regulation.
  • Further research into OI pathogenesis is crucial for developing effective therapeutic strategies.